| SERES THERAPEUTICS |
| USA |
| Gesundheit |
| US81750R2013 / A413XF |
| 1S90 (Frankfurt) / MCRB (NASDAQ) |
| FRA:1S90, ETR:1S90, 1S90:GR, NASDAQ:MCRB |
| - |
| https://www.serestherapeu.. |
|
Seres Therapeutics, Inc. is a clinical-stage biotechnology company specializing in the development of live biotherapeutic products that utilize carefully selected consortia of live bacteria to modulat..
>Volltext.. |
| 70.11 Mio. EUR |
| 101.92 Mio. EUR |
| 0.3 Mio. EUR |
| -84.32 Mio. EUR |
| 4.68 Mio. EUR |
| 0.53 EUR |
| 72 Mio. EUR |
| 39.72 Mio. EUR |
| -20.01 Mio. EUR |
| 2.37 |
| 420.38% |
| - |
| - |
| - |
| - |
| SERES THERAPEUTICS, SERES THERAPEUTIC |
| 13.03.26 |
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|